精神医学64巻1号

2022年01月発行

展望

注意欠如・多動症(ADHD)と自閉スペクトラム症(ASD)—小児の併存例の診断と治療を中心に

著者： 太田豊作¹ 堀江純子² 鈴木千尋² 難波佑貴³ 飯田順三⁴ 氏家武⁵

所属機関： ¹奈良県立医科大学医学部看護学科人間発達学 ²武田薬品工業株式会社ジャパンメディカルオフィス ³塩野義製薬株式会社メディカルアフェアーズ部 ⁴医療法人南風会万葉クリニック子どものこころセンター絆 ⁵氏家記念こどもクリニック

ページ範囲：P.83 - P.94

文献概要

抄録　近年，注意欠如・多動症(attention-deficit/hyperactivity disorder：ADHD)と自閉スペクトラム症(autism spectrum disorder：ASD)を併存する患児が数多く報告されている。また，ADHDとASDを併存(以下，ADHD＋ASD)した場合，いずれか単独よりも症状が重症化すること，さらにうつ病などの他の精神疾患を併存する可能性が高いことも明らかとなっている。このことから，ADHD＋ASDを適切に診断し治療することが重要である。そこで本総説では，ADHDとASDの特徴，類似点および相違点，ADHD＋ASDの診断と治療法について解説する。

参考文献

1)American Psychiatric Association：Diagnostic and Statistical Manual of Mental Disorders, Fifth ed.(DSM-5), 5th Edition. American Psychiatric Publishing, Washington D.C., 2013(日本精神神経学会日本語版用語監修，髙橋三郎，大野裕監訳：DSM-5精神疾患の診断・統計マニュアル．医学書院，2014)

2)World Health Organization：ICD-11 for Mortality and Morbidity Statistics.　https://icd.who.int/browse11/lm/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f437815624(2021年11月1日閲覧)

3)Xu G, Strathearn L, Liu B, et al：Prevalence of autism spectrum disorder among us children and adolescents, 2014-2016. JAMA 319：81-82, 2018

4)Narzisi A, Posada M, Barbieri F, et al：Prevalence of autism spectrum disorder in a large Italian catchment area：a school-based population study within the ASDEU project. Epidemiol Psychiatr Sci 29：e5, 2018

5)American Psychiatric Association：Diagnostic and Statistical Manual of Mental Disorders, Fourth ed. Text Revision(DSM-IV-TR). American Psychiatric Publishing, Washington D.C., 2000(髙橋三郎，大野裕，染矢俊幸訳：DSM-IV-TR精神疾患の診断・統計マニュアル．新訂版．医学書院，2002)

6)World Health Organization：ICD-10 Classification of Mental and Behavioural Disorder.　https://icd.who.int/browse10/2016/en#/V(2021年11月1日閲覧)

7)Kotte A, Joshi G, Fried R, et al：Autistic traits in children with and without ADHD. Pediatrics 132：e612-e622, 2013

8)Jensen MC, Steinhausen HC：Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Atten Defic Hyperact Disord 7：27-38, 2015

9)Gordon-Lipkin E, Marvin AR, Law JK, et al：Anxiety and mood disorder in children with autism spectrum disorder and ADHD. PEDIATRICS 141：e20171377, 2018

10)Antshel KM, Zhang-James Y, Wagner KE, et al：An update on the comorbidity of ADHD and ASD：a focus on clinical management. Expert Rev Neurother 16：279-293, 2016

11)根来秀樹，大西貴子：ASDとADHDの鑑別と併存．小児科診療 12：1765-1769, 2014

12)Young S, Hollingdale J, Absoud M, et al：Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. BMC Med 18：146, 2020

13)Taurines R, Schwenck C, Westerwald E, et al：ADHD and autism：differential diagnosis or overlapping traits? A selective review. Atten Defic Hyperact Disord 4：115-139, 2012

14)Rommelse NN, Geults HM, Franke B, et al：A review on cognitive and brain endophenotypes that may be common in autismspectrum disorder and attention-deficit/hyperactivity disorder and facilitate thesearch for pleiotropic genes. Neurosci Biobehav Rev 35：1363-1396, 2011

15)Canadian ADHD Resource Alliance：Canadian ADHD Practice Guidelines, 4.1 ed. 2020　https://www.caddra.ca/canadian-adhd-practice-guidelines(2021年11月1日閲覧)

16)Antshel KM, Russo N：Autism spectrum disorders and ADHD：overlapping phenomenology, diagnostic issues, and treatment considerations. Curr Psychiatry Rep 21, 2019

17)Miyasaka M, Kajimura S, Nomura M：Biases in understanding attention deficit hyperactivity disorder and autism spectrum disorder in Japan. Front Psychol 9：244, 2018

18)Avni E, Ben-Itzchak E, Zachor DA：The presence of comorbid ADHD and anxiety symptoms in autism spectrum disorder：clinical presentation and predictors. Front Psychiatry 9：717, 2018

19)Stevens S, Peng L, Barnard-Brak L：The comorbidity of ADHD in children diagnosed with autism spectrum disorder. Res Autism Spectr Disord 31：11-18, 2016

20)Dougherty CC, Evans DV, Myers SM, et al：A comparison of structural brain imaging findings in autism spectrum disorder and attention-deficit hyperactivity disorder. Neuropsychol Rev 26：25-43, 2016

21)Baribeau DA, Dupuis A, Paton TA, et al：Structural neuroimaging correlates of social deficits are similar in autism spectrum disorder and attention-deficit/hyperactivity disorder：analysis from the POND Network. Transl Psychiatry 9：72, 2019

22)Faraone SV, Larsson H：Genetics of attention deficit hyperactivity disorder. Mol Psychiatry 24：562-575, 2019

23)Freitag CM：The genetics of autistic disorders and its clinical relevance. Mol Psychiatry 12：2-22, 2007

24)Martin J, Cooper M, Hamshere ML, et al：Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder：evidence from copy number variants. J Am Acad Child Adolesc Psychiatry 53：761-770, 2014

25)Walton E, Pingault JB, Cecil CA, et al：Epigenetic profiling of ADHD symptoms trajectories：a prospective, methylome-wide study. Mol Psychiatry 22：250-256, 2016

26)Canadian Paediatric Society：ADHD in children and youth：part 3—assessment and treatment with comorbid ASD, ID, or prematurity. 2018　https://www.cps.ca/en/documents/position/adhd-comorbid-asd-id-or-prematurity(2021年11月1日閲覧)

27)National Institute for Health and Care Excellence：Autism spectrum disorder in under 19s：recognition, referral and diagnosis. 2017　https://www.nice.org.uk/guidance/cg128(2021年11月1日閲覧)

28)National Institute for Health and Care Excellence：Attention deficit hyperactivity disorder：diagnosis and management. 2018　https://www.nice.org.uk/guidance/ng87(2021年11月1日閲覧)

29)Anagnostou E, Zwaigenbaum L, Szatmari P, et al：Autism spectrum disorder：advances in evidence-based practice. CMAJ 186：509-519, 2014

30)齊藤万比古：注意欠如・多動症—ADHD—の診断・治療ガイドライン．じほう，2016

31)中村和彦編：児童・青年期精神疾患の薬物治療ガイドライン．じほう，2018

32)市川宏伸監修：診断・対応のためのADHD評価スケール—ADHD-RS(DSM準拠)—チェックリスト，標準値とその臨床的解釈．明石書店，2008

日本語版．金子書房，2012)

34)Adler L, Kessler RC, Spencer T：Adult ADHD Self-Report Scale(ASRS-v1.1)Symptom Checklist Instructions.　https://add.org/wp-content/uploads/2015/03/adhd-questionnaire-ASRS111.pdf(2021年11月1日閲覧)

35)New York University and President and Fellows of Harvard College：Adult ADHD Self-Report Screening Scale for DSM-5(ASRS-5). 2017　https://www.hcp.med.harvard.edu/ncs/ftpdir/adhd/ASRS-5_English.pdf(2021年11月1日閲覧)

36)Couteur AL, Lord C, Rutter M：Autism Diagnostic Interview-Revised. Western Psychological Services, Los Angeles, 2003(ADI-R日本語版研究会監訳：ADI-R日本語版．金子書房，2013)

日本語版．金子書房，2012)

38)DIVA Foundation：成人用ADHD診断面接(DIVA)2.0日本語版. Haag, 2010　https://www.divacenter.eu/Content/VertalingPDFs/DIVA_2_Japanese_form.pdf(2021年11月1日閲覧)

. 1999　https://m-chat.org/en-us/(2021年11月1日閲覧)

40)Lord C, Rutter M, DiLavore PC, et al：Autism Diagnostic Observation Schedule, Second Edition. Western Psychological Services, Los Angeles, 2012(黒田美保，稲田尚子監修監訳：ADOS-2日本語版マニュアル．金子書房，2015)

41)Schopler E, van Bourgondien ME, Wellman GJ, et al：Childhood Autism Rating Scale Second Edition. Western Psychological Services, Los Angeles, 2010(内山登紀夫，黒田美保，稲田尚子監修監訳：CARS2日本語版．金子書房，2020)

-TR．金子書房，2018

43)Kurita H, Koyama T, Osada H：Autism-Spectrum Quotient-Japanese version and its short forms for screening normally intelligent persons with pervasive developmental disorders. Psychiatry Clin Neurosci 59：490-496, 2005

44)中村和彦編著：大人のADHD—臨床アセスメントから治療まで．金子書房，pp128-137, 2015

45)Myers SM, Johnson CP：The council on children with disabilities：management of children with autism spectrum disorders. Pediatrics 120：1162-1182, 2007

46)Politte LC, Scahill L, Figueroa J, et al：A randomized, placebo-controlled trial of extended-releaseguanfacine in children with autism spectrum disorder and ADHD symptoms：an analysis of secondary outcome measures. Neuropsychopharmacology 43：1772-1778, 2018

47)Sturman N, Deckx L, van Driel ML：Methylphenidate for children and adolescents with autism spectrum disorder. Cochrane Database Syst Rev. doi：10.1002/14651858.CD011144.pub2, 2017

48)Harfterkamp M, van de Loo-Neus G, Minderaa RB, et al：A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 51：733-741, 2012

49)Scahill L, McCracken JT, King BH, et al：Extended-release guanfacine for hyperactivity in children with autism spectrum disorder. Am J Psychiatry 172：1197-1206, 2015

50)McCracken JT, McGough J, Shah B, et al：Risperidone in children with autism and serious behavioral problems. N Engl J Med 347：314-321, 2002

51)Mayes SD, Calhoun SL, Waxmonsky JG, et al：Demographic differences in disruptive mood dysregulation disorder symptoms in ADHD, autism, and general population samples. J Atten Disord 23：849-885, 2019